相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A 3-Plex Methylation Assay Combined with the FGFR3 Mutation Assay Sensitively Detects Recurrent Bladder Cancer in Voided Urine
Raju Kandimalla et al.
CLINICAL CANCER RESEARCH (2013)
DNA methylation-based biomarkers in bladder cancer
Raju Kandimalla et al.
NATURE REVIEWS UROLOGY (2013)
Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers
Raju Kandimalla et al.
EUROPEAN UROLOGY (2012)
RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer
Chunri Yan et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer
Bas W. G. van Rhijn
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non-Muscle-Invasive Bladder Cancer
Bas W. G. van Rhijn et al.
EUROPEAN UROLOGY (2010)
The Pathologist's Mean Grade Is Constant and Individualizes the Prognostic Value of Bladder Cancer Grading
Bas W. G. van Rhijn et al.
EUROPEAN UROLOGY (2010)
Prognostic Accuracy of Individual Uropathologists in Noninvasive Urinary Bladder Carcinoma: A Multicentre Study Comparing the 1973 and 2004 World Health Organisation Classifications
Matthias May et al.
EUROPEAN UROLOGY (2010)
Recurrence and Progression of Disease in Non-Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
Bas W. G. van Rhijn et al.
EUROPEAN UROLOGY (2009)
Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison
Madelon N. M. van der Aa et al.
BJU INTERNATIONAL (2008)
Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer
Carmen J. Marsit et al.
CARCINOGENESIS (2007)
Prognostic factors in non-muscle-invasive bladder tumors - I. Clinical prognostic factors: A review of the experience of the EORTC genito-urinary group - II. Biologic prognostic markers
Karl-Heinz Kurth et al.
EUROPEAN UROLOGY SUPPLEMENTS (2007)
Promoter hypermethylation identifies progression risk in bladder cancer
David R. Yates et al.
CLINICAL CANCER RESEARCH (2007)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
MA Knowles
CARCINOGENESIS (2006)
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
M Sanchez-Carbayo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma
MG Friedrich et al.
EUROPEAN JOURNAL OF CANCER (2005)
Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma
JWF Catto et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Quality of life aspects of bladder cancer: A review of the literature
MF Botteman et al.
QUALITY OF LIFE RESEARCH (2003)
Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome
BWG van Rhijn et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder
MGW Bol et al.
JOURNAL OF UROLOGY (2003)
The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: A combined analysis of 5 European organization for research and treatment of cancer trials
A Van Der Meijden et al.
JOURNAL OF UROLOGY (2000)
分享论文
